JP2004517081A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004517081A5 JP2004517081A5 JP2002546529A JP2002546529A JP2004517081A5 JP 2004517081 A5 JP2004517081 A5 JP 2004517081A5 JP 2002546529 A JP2002546529 A JP 2002546529A JP 2002546529 A JP2002546529 A JP 2002546529A JP 2004517081 A5 JP2004517081 A5 JP 2004517081A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- treatment
- urinary incontinence
- combination
- receptor agonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000018 receptor agonist Substances 0.000 claims 7
- 229940044601 receptor agonist Drugs 0.000 claims 7
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 206010046543 Urinary incontinence Diseases 0.000 claims 5
- 206010037211 Psychomotor hyperactivity Diseases 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 4
- 239000000969 carrier Substances 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- DFMQXSQHKBNHNU-UHFFFAOYSA-N n-[3-[2-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]ethyl]phenyl]methanesulfonamide;hydrochloride Chemical compound Cl.CS(=O)(=O)NC1=CC=CC(CCN2CCN(CC2)C=2C=C(C=CC=2)C(F)(F)F)=C1 DFMQXSQHKBNHNU-UHFFFAOYSA-N 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25020300P | 2000-11-29 | 2000-11-29 | |
| PCT/US2001/042949 WO2002044159A2 (en) | 2000-11-29 | 2001-11-16 | 1-(2-m-methanesulfonamidophenylethyl)-4-(m-trifluoromethylphenyl)piperazine and pharmaceutically acceptable salts and solvates thereof and their use in the treatment of incontinence |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004517081A JP2004517081A (ja) | 2004-06-10 |
| JP2004517081A5 true JP2004517081A5 (https=) | 2005-11-17 |
Family
ID=22946725
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002546529A Pending JP2004517081A (ja) | 2000-11-29 | 2001-11-16 | １−（２−ｍ−メタンスルホンアミドフェニルエチル）−４−（ｍ−トリフルオロメチルフェニル）ピペラジンならびにその医薬的に許容しうる塩および溶媒和物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6864262B2 (https=) |
| EP (1) | EP1341777B1 (https=) |
| JP (1) | JP2004517081A (https=) |
| AT (1) | ATE374192T1 (https=) |
| AU (1) | AU2002230411A1 (https=) |
| CA (1) | CA2427098A1 (https=) |
| DE (1) | DE60130677T2 (https=) |
| ES (1) | ES2292636T3 (https=) |
| WO (1) | WO2002044159A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2611376C2 (ru) | 2010-10-15 | 2017-02-21 | Контера Фарма Апс | Фармацевтическая композиция для лечения, профилактики или облегчения двигательных расстройств и ее применение |
| NZ700474A (en) | 2012-04-18 | 2016-10-28 | Contera Pharma Aps | Orally available pharmaceutical formulation suitable for improved management of movement disorders |
| AU2017297718B2 (en) | 2016-07-11 | 2023-06-08 | Contera Pharma A/S | Pulsatile drug delivery system for treating morning akinesia |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB948766A (en) | 1959-10-20 | 1964-02-05 | May & Baker Ltd | Trifluoromethylphenylpiperazine derivatives |
| BE755015A (fr) | 1969-08-20 | 1971-02-01 | Byk Gulden Lomberg Chem Fab | Piperazinyl-alcoylamino-uraciles substitues par un groupe aryle, leurs ethers et thioethers, ainsi que leur procede de preparation |
| BE759371A (fr) | 1969-11-24 | 1971-05-24 | Bristol Myers Co | Azaspirodecanediones heterocycliques et procedes pour leur preparation |
| FR2362628A1 (fr) | 1976-08-26 | 1978-03-24 | Roussel Uclaf | Nouveaux derives du piperidyl-indole et leurs sels, procede de preparation et application a titre de medicaments |
| US4423049A (en) | 1981-12-28 | 1983-12-27 | Mead Johnson & Company | 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines |
| DE3321969A1 (de) | 1983-06-18 | 1984-12-20 | Troponwerke GmbH & Co KG, 5000 Köln | 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel |
| AU577802B2 (en) | 1983-10-17 | 1988-10-06 | Duphar International Research B.V. | Blood-pressure lowering piperazine derivatives |
| EP0303507B1 (en) | 1987-08-13 | 1993-07-28 | Glaxo Group Limited | Indole derivatives |
| JPH03502701A (ja) | 1988-12-15 | 1991-06-20 | アボツト・ラボラトリーズ | ５‐ｈｔ選択性物質 |
| PT97888B (pt) | 1990-06-07 | 1998-12-31 | Zeneca Ltd | Processo para a preparacao de compostos heterociclicos derivados de indol e de composicoes farmaceuticas que os contem |
| US5545644A (en) | 1990-10-15 | 1996-08-13 | Pfizer Inc. | Indole derivatives |
| SK278998B6 (sk) | 1991-02-01 | 1998-05-06 | Merck Sharp & Dohme Limited | Deriváty imidazolu, triazolu a tetrazolu, spôsob i |
| PT533268E (pt) | 1991-09-18 | 2002-02-28 | Glaxo Group Ltd | Derivados de benzanilida como antagonistas de 5-ht1d |
| CA2084531A1 (en) | 1991-12-19 | 1993-06-20 | David W. Smith | Antimigraine 4-pyrimidinyl and pyridinyl derivatives of indol-3yl-alkyl piperazines |
| SI9300097B (en) | 1992-02-27 | 2001-12-31 | Janssen Pharmaceutica Nv | (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines |
| US5521188A (en) | 1993-09-16 | 1996-05-28 | Bristol-Myers Squibb Company | Antimigraine cyclobutenedione derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines |
| EP0733048A1 (en) | 1993-12-07 | 1996-09-25 | Smithkline Beecham Plc | Heterocyclic biphenylylamides useful as 5ht1d antagonists |
| SE9504661D0 (sv) | 1995-12-22 | 1995-12-22 | Astra Pharma Inc | New compounds |
| AU736510B2 (en) * | 1997-06-27 | 2001-07-26 | Nippon Kayaku Kabushiki Kaisha | Remedies/preventives for frequent urination/urinary incontinence and tropone derivatives |
| JP3441636B2 (ja) | 1997-11-21 | 2003-09-02 | 株式会社エヌ・ティ・ティ・ドコモ | チャネル推定値を求める装置および方法、受信装置ならびに伝送システム |
-
2001
- 2001-11-16 AT AT01990644T patent/ATE374192T1/de not_active IP Right Cessation
- 2001-11-16 JP JP2002546529A patent/JP2004517081A/ja active Pending
- 2001-11-16 CA CA002427098A patent/CA2427098A1/en not_active Abandoned
- 2001-11-16 AU AU2002230411A patent/AU2002230411A1/en not_active Abandoned
- 2001-11-16 DE DE60130677T patent/DE60130677T2/de not_active Expired - Fee Related
- 2001-11-16 ES ES01990644T patent/ES2292636T3/es not_active Expired - Lifetime
- 2001-11-16 WO PCT/US2001/042949 patent/WO2002044159A2/en not_active Ceased
- 2001-11-16 EP EP01990644A patent/EP1341777B1/en not_active Expired - Lifetime
- 2001-11-16 US US10/432,413 patent/US6864262B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR20C1018I1 (fr) | Composition pharmaceutique comprenant du glycopyrrolate et un agoniste du récepteur beta2 adrénergique | |
| JP2004532209A5 (https=) | ||
| ATE401066T1 (de) | Methoden zur behandlung der essstörungen | |
| WO2005051946A3 (en) | Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity | |
| JP2005531488A5 (https=) | ||
| SE0300010D0 (sv) | Novel Compounds | |
| EP2298757A3 (en) | Urea compounds active as vanilloid receptor antagonist for the treatment of pain | |
| KR950016746A (ko) | 비-펩티드 타키키닌 수용체 길항물질 | |
| JP2003012668A5 (https=) | ||
| AU2003250471A8 (en) | Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors | |
| JP2004517081A5 (https=) | ||
| WO2005118579A3 (en) | Thiazole derivatives as chemokine receptor antagonists | |
| JP2007533655A5 (https=) | ||
| ATE380189T1 (de) | 2-amino-5-benzoylthiazol npy-antagonisten | |
| KR950016741A (ko) | 체중 증가를 억제하거나 또는 체중 감소를 유도하는 방법 | |
| JP2005513103A5 (https=) | ||
| JP2008508350A5 (https=) | ||
| JP2007506780A5 (https=) | ||
| JP2005509674A5 (https=) | ||
| AR048948A1 (es) | Una composicion farmaceutica antimicobacteriana | |
| CO5261525A1 (es) | Forma poliformica de un antagonista de los receptores de las taquiquininas . | |
| JP2005516066A5 (https=) | ||
| JP2004508372A5 (https=) | ||
| RU2009118439A (ru) | Средство для профилактики или лечения алкогольной зависимости и зависимости от лекарственных веществ | |
| HK1045254A1 (zh) | 降低血小板黏性的处理方法 |